Page last updated: 2024-09-04

canertinib and Hearing Loss

canertinib has been researched along with Hearing Loss in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, J; Chen, X; DeCook, R; Ding, D; Kobel, M; Kopecky, BJ; Li, H; Ou, HC; Qian, Y; Sun, Z; Tang, J	1

Other Studies

1 other study(ies) available for canertinib and Hearing Loss

Article	Year
Canertinib induces ototoxicity in three preclinical models. Hearing research, 2015, Volume: 328 Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Screening Assays, Antitumor; Ear; Electrophysiology; ErbB Receptors; Female; Hair Cells, Auditory, Outer; Hearing; Hearing Loss; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Morpholines; Neuregulin-1; Signal Transduction; Zebrafish	2015

Article

Year

Canertinib induces ototoxicity in three preclinical models.

Hearing research, 2015, Volume: 328

Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Screening Assays, Antitumor; Ear; Electrophysiology; ErbB Receptors; Female; Hair Cells, Auditory, Outer; Hearing; Hearing Loss; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Morpholines; Neuregulin-1; Signal Transduction; Zebrafish

2015